Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Autoimmune Diseases × Plasma Exchange × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rare Diseases 1 Paraproteinemias 1 Neuromyelitis Optica 1 Neurologic Manifestations 1 Nervous System Diseases 1 Myelitis, Transverse 1 Multiple Sclerosis 1 Mental Disorders 1 Kidney Diseases 1 Hematologic Diseases 1 Encephalomyelitis, Acute Disseminated 1 Diffuse Cerebral Sclerosis of Schilder 1 Autoimmune Diseases 1

Interventions

telitacicept 1 Plasma Exchange 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01210716 2013-09-23

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

Fenwal, Inc.

Phase 3 Completed

37 enrolled 7 charts

Autoimmune Diseases, Hematologic Diseases, Kidney Diseases, Nervous System Diseases, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡